A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions

Not Applicable

• Conditions: Healthy adult

• Registration Number: JPRN-UMIN000039671
• Lead Sponsor: TTC Co., Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-12-31
• Study Start: 2021-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who constantly use health food richly containing involvement ingredient (2) Subjects who regularly take drugs or health foods which may affect this study more than once a week (3) Subjects whose visual acuity is too low to perform test (4) Subjects whose hearing acuity is too low to perform test (5) Subjects having a disease of mental disorder, dementia, cranial nerve disease, or cerebrovascular disease. (6) Subjects with current menopausal disorders (7) Subjects taking drugs that may affect the results of the study (8) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (9) Subjects having a drug dependence, alcohol dependence requiring treatment or a history of serious alcohol dependence (10) Subjects suspected of having dementia based on cognitive function tests and physician interviews. (11) Subjects who may experience irregularities in their lives more than once during the study period due to night shifts, etc. (12) Subjects who are current smokers or have started smoking cessation within 12 months before the pre-treatment test. (13) Subjects who have performed the cognitive tests within 12 months prior to the pre-treatment test. (14) Subjects who donated or transfused 200 mL or 400 mL of whole blood within 3 months before the pre-treatment test. (15) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study. (16) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on the pre-treatment test. (17) Subjects at risk of developing allergy in relation to the study. (18) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (19) Subjects judged as unsuitable for the study by the investigator for other reasons.

Study & Design

• Study Type: Interventional
• Study Design: Not specified